Commentary

Young children with neuromuscular disease are vulnerable to respiratory viruses

Publish date: May 15, 2019

 

References

1. Pediatr Infect Dis J. 2019 Apr 10. doi: 10.1097/INF.0000000000002297.

2. “Advances in RSV Vaccine Research and Development – A Global Agenda.”

3. J Pediatric Infect Dis Soc. 2015 Dec;4(4): e143-6.

4. J Virol. 2015 Oct;89(20):10319-32.

5. Vaccine. 2017 Dec 18;35(51):7139-46.

Pages

Recommended Reading

DOPPS participation associated with lower HCV rates in dialysis patients
MDedge Infectious Disease
Zero HIV transmission rate when viral load suppressed
MDedge Infectious Disease
Rotavirus vaccine had strong protective effect in routine U.K. practice
MDedge Infectious Disease
No exudates or fever? Age over 11? Skip strep test
MDedge Infectious Disease
N.Y. hospitals report near-universal CMV screening when newborns fail hearing tests
MDedge Infectious Disease
U.S. measles cases climb to over 800 for the year
MDedge Infectious Disease
Flu vaccine visits reveal missed opportunities for HPV vaccination
MDedge Infectious Disease
Infections within first year of life predicted IBD
MDedge Infectious Disease
Is it measles? – Diagnosis and management for the pediatric provider
MDedge Infectious Disease
Measles complications in the U.S. unchanged in posteradication era
MDedge Infectious Disease